Gao, Y., Wang, W., Zhi, Q., Shen, M., Jiang, M., Bian, X., . . . Li, W. (2017). Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer. Oncotarget.
Chicago Style CitationGao, Yuan, et al. "Neutrophil/lymphocyte Ratio Is a More Sensitive Systemic Inflammatory Response Biomarker Than Platelet/lymphocyte Ratio in the Prognosis Evaluation of Unresectable Pancreatic Cancer." Oncotarget 2017.
Cita MLAGao, Yuan, et al. "Neutrophil/lymphocyte Ratio Is a More Sensitive Systemic Inflammatory Response Biomarker Than Platelet/lymphocyte Ratio in the Prognosis Evaluation of Unresectable Pancreatic Cancer." Oncotarget 2017.